Miyagishi A - Search Results

1

Activation of Na(+)-H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system.

Takewaki S, Kuro-o M, Hiroi Y, Yamazaki T, Noguchi T, Miyagishi A, Nakahara K, Aikawa M, Manabe I, Yazaki Y, et al. Takewaki S, et al. Among authors: miyagishi a. J Mol Cell Cardiol. 1995 Jan;27(1):729-42. doi: 10.1016/s0022-2828(08)80063-6. J Mol Cell Cardiol. 1995. PMID: 7760389

2

Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger.

Kuro-o M, Hanaoka K, Hiroi Y, Noguchi T, Fujimori Y, Takewaki S, Hayasaka M, Katoh H, Miyagishi A, Nagai R, et al. Kuro-o M, et al. Among authors: miyagishi a. Circ Res. 1995 Jan;76(1):148-53. doi: 10.1161/01.res.76.1.148. Circ Res. 1995. PMID: 8001273

3

Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.

Miyagishi A, Maniwa T, Noguchi T, Hara Y. Miyagishi A, et al. Clin Exp Hypertens A. 1991;13(5):1077-89. doi: 10.3109/10641969109042114. Clin Exp Hypertens A. 1991. PMID: 1723031

4

Synthesis and biological activity of N-(aminoiminomethyl)-1H-indole carboxamide derivatives as Na+/H+ exchanger inhibitors.

Kitano M, Kojima A, Nakano K, Miyagishi A, Noguchi T, Ohashi N. Kitano M, et al. Among authors: miyagishi a. Chem Pharm Bull (Tokyo). 1999 Nov;47(11):1538-48. doi: 10.1248/cpb.47.1538. Chem Pharm Bull (Tokyo). 1999. PMID: 10605052

5

Cardioprotection of SM-15681, an Na+/H+ exchange inhibitor in ischemic and hypoxic isolated perfused rat hearts.

Toda H, Noguchi T, Miyagishi A, Ito N, Umekawa K, Sato Y, Kitano M, Ohashi N. Toda H, et al. Among authors: miyagishi a. Int J Tissue React. 1999;21(3):61-70. Int J Tissue React. 1999. PMID: 10645513

6

[Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].

Hara Y, Nakahara H, Miyagishi A, Nakatani H. Hara Y, et al. Among authors: miyagishi a. Nihon Yakurigaku Zasshi. 1983 Aug;82(2):103-16. Nihon Yakurigaku Zasshi. 1983. PMID: 6198264 Japanese.

7

Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.

Miyagishi A, Nakahara H, Hara Y. Miyagishi A, et al. Arch Int Pharmacodyn Ther. 1984 Oct;271(2):249-62. Arch Int Pharmacodyn Ther. 1984. PMID: 6210068

8

Synthesis and beta-adrenergic blocking action of a new thiazolylthiopropanolamine derivative.

Hara Y, Sato E, Miyagishi A, Aisaka A, Hibino T. Hara Y, et al. Among authors: miyagishi a. J Pharm Sci. 1978 Sep;67(9):1334-5. doi: 10.1002/jps.2600670944. J Pharm Sci. 1978. PMID: 29117

9

Assessment of Ca(2+)-antagonistic effect of SM-6586 and its isomers, novel 1,4-dihydropyridine derivatives, by radioligand binding assay.

Kinami J, Qu YL, Tsuchihashi H, Nagatomo T, Maniwa T, Miyagishi A. Kinami J, et al. Among authors: miyagishi a. Jpn J Pharmacol. 1992 Jan;58(1):75-8. doi: 10.1254/jjp.58.75. Jpn J Pharmacol. 1992. PMID: 1640663 Free article.

10

Calcium channel blocking properties of SM-6586 in rat heart and brain as assessed by radioligand binding assay.

Qu YL, Sugiyama K, Nagatomo T, Maniwa T, Miyagishi A. Qu YL, et al. Among authors: miyagishi a. Jpn J Pharmacol. 1993 Oct;63(2):165-9. doi: 10.1254/jjp.63.165. Jpn J Pharmacol. 1993. PMID: 8283826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters